Financials

News Discussions Technicals Seasonals

MYND fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

MYND Life Sciences, Inc. is a neuro-pharmaceutical drug development company. It develops medicines based on neuro-anti-inflammatory substances through rigorous science with an initial focus on Major Depressive Disorder (“MDD”). The company was founded by Dr. Lyle Oberg and Dr. Wilfred Jefferies on July 6, 2018 and is headquartered in Kelowna, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

MYND has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company